BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18249158)

  • 1. Disease progression and evolution of the HIV-1 env gene in 24 infected infants.
    Carvajal-Rodríguez A; Posada D; Pérez-Losada M; Keller E; Abrams EJ; Viscidi RP; Crandall KA
    Infect Genet Evol; 2008 Mar; 8(2):110-20. PubMed ID: 18249158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of temporal structure in the short term HIV-1 evolution within asymptomatic naïve patients.
    Bello G; Casado C; García S; Rodríguez C; del Romero J; Carvajal-Rodriguez A; Posada D; López-Galíndez C
    Virology; 2007 Jun; 362(2):294-303. PubMed ID: 17275055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression.
    Williamson S
    Mol Biol Evol; 2003 Aug; 20(8):1318-25. PubMed ID: 12777505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A statistical characterization of consistent patterns of human immunodeficiency virus evolution within infected patients.
    Williamson S; Perry SM; Bustamante CD; Orive ME; Stearns MN; Kelly JK
    Mol Biol Evol; 2005 Mar; 22(3):456-68. PubMed ID: 15509726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term intrapatient viral evolution during HIV-2 infection.
    MacNeil A; Sankale JL; Meloni ST; Sarr AD; Mboup S; Kanki P
    J Infect Dis; 2007 Mar; 195(5):726-33. PubMed ID: 17262716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of positive and negative selection in the molecular evolution of insect endosymbionts.
    Fry AJ; Wernegreen JJ
    Gene; 2005 Aug; 355():1-10. PubMed ID: 16039807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for negative selective pressure in HIV-2 evolution in vivo.
    Barroso H; Taveira N
    Infect Genet Evol; 2005 Apr; 5(3):239-46. PubMed ID: 15737915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of drug-injection behavior on genetic evolution of HIV-1.
    Carneiro M; Yu XF; Lyles C; Templeton A; Weisstein AE; Safaeian M; Farzadegan H; Vlahov D; Markham RB
    J Infect Dis; 1999 Oct; 180(4):1025-32. PubMed ID: 10479127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between sequence variation of Env, Gag genes from the same source and HIV-1 disease progression and host genetic polymorphism].
    Bai LS; Wang KL; Zhou GE; Meng B; Liu YC; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):153-5. PubMed ID: 17653321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic analysis of genetic diversity of gag and env regions of HIV-1 CRF07_BC recombinant in intravenous drug users in Xinjiang Uvghur Autonomous Region, China.
    Liu S; Xing H; He X; Xin R; Zhang Y; Zhu J; Shao Y
    Arch Virol; 2008; 153(7):1233-40. PubMed ID: 18504522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains.
    Chalmet K; Van Wanzeele F; Demecheleer E; Dauwe K; Pelgrom J; Van Der Gucht B; Vogelaers D; Plum J; Stuyver L; Vandekerckhove L; Verhofstede C
    Virology; 2008 Sep; 379(2):213-22. PubMed ID: 18692212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamic variation of HIV-1 CRF07_BC env gene in early HIV-1 infection].
    Liu SY; Xing H; Zhang YZ; Ruan YH; Quan Y; Zhu JH; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):290-2. PubMed ID: 19105347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression.
    Marcelino JM; Nilsson C; Barroso H; Gomes P; Borrego P; Maltez F; Rosado L; Doroana M; Antunes F; Taveira N
    AIDS; 2008 Nov; 22(17):2257-65. PubMed ID: 18981765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function.
    McDonald RA; Mayers DL; Chung RC; Wagner KF; Ratto-Kim S; Birx DL; Michael NL
    J Virol; 1997 Mar; 71(3):1871-9. PubMed ID: 9032317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV evolutionary dynamics within and among hosts.
    Lemey P; Rambaut A; Pybus OG
    AIDS Rev; 2006; 8(3):125-40. PubMed ID: 17078483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of intrahost HIV-1 genetic diversity during chronic infection.
    Shriner D; Liu Y; Nickle DC; Mullins JI
    Evolution; 2006 Jun; 60(6):1165-76. PubMed ID: 16892967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 molecular evolution and the measure of selection.
    Rodrigo AG; Mullins JI
    AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1681-5. PubMed ID: 8959243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
    Repits J; Sterjovski J; Badia-Martinez D; Mild M; Gray L; Churchill MJ; Purcell DF; Karlsson A; Albert J; Fenyö EM; Achour A; Gorry PR; Jansson M
    Virology; 2008 Sep; 379(1):125-34. PubMed ID: 18672260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
    Derache A; Maiga AI; Traore O; Akonde A; Cisse M; Jarrousse B; Koita V; Diarra B; Carcelain G; Barin F; Pizzocolo C; Pizarro L; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2008 Sep; 62(3):456-63. PubMed ID: 18556706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.